Biosimilars Poised to Impact Specialty Pharmacy

Amy Grogg, PharmD, senior vice president of Strategy and Commercialization at AmerisourceBergen Specialty Group, discusses the projected ramifications from the launch of biosimilars in the United States.

Amy Grogg, PharmD, senior vice president of Strategy and Commercialization at AmerisourceBergen Specialty Group, discusses the projected ramifications from the launch of biosimilars in the United States.

This video was recorded courtesy of Armada Health Care at the 2015 Armada Specialty Pharmacy Summit in Las Vegas, Nevada.

Related Videos
sofiko14 / stock.adobe.com
Mammogram scans | Image credit: okrasiuk - stock.adobe.com
WP_7824 / stock.adobe.com
tilialucida / stock.adobe.com
vectorfusionart / stock.adobe.com
Related Content
© 2023 MJH Life Sciences

All rights reserved.